Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
Theranostics|January 12, 2023
Three-dimensional mapping of hepatic lymphatic vessels and transcriptome profiling of lymphatic endothelial cells in healthy and diseased liversSonglin Huang, Borui Li, Zheng Liu, et al.
Communications Biology|April 4, 2025
The crosstalk of monocyte-neutrophil in hair follicles regulates neutrophil transepidermal migration in contact dermatitisZhan Fan, Yilun Xu, Yafang Lu, et al.
Ejhaem|June 19, 2024
Stable engraftment, as well as graft versus host disease-free and relapse-free survival brought by the combination of CD7 targeted universal chimeric antigen receptor-T, and donor hemopoietic stem cells: Indication of a case reportShiqi Li, Zhongtao Yuan, Lin Liu, et al.
Theranostics|August 1, 2022
Mesoscale visualization of three-dimensional microvascular architecture and immunocyte distribution in intact mouse liver lobesZheng Liu, Mengli Xu, Songlin Huang, et al.
BMC Genomics|October 24, 2025
Identification and functional analysis of circular RNAs during mitochondrial damage induced by infectious bovine rhinotracheitis virus infection in Madin-Darby bovine kidney cellsYingcai Ma, Jiaxin Liu, Lianping Xu, et al.
Trends in Biotechnology|April 8, 2025
Long-offset paired nicking-based efficient and precise strategy for in vivo targeted insertionYafang Lu, Jialu Wang, Yilun Xu, et al.
Journal of Thoracic Disease|September 13, 2024
Neoadjuvant camrelizumab followed by concurrent camrelizumab plus chemotherapy for locally advanced esophageal squamous cell carcinoma: a single-arm, phase II studyYinliang Sheng, Xiangrui Meng, Chunyang Zhang, et al.
Nature Immunology|June 19, 2025
Neuroprotective liver portal area macrophages attenuate hepatic inflammationMengli Xu, Zheng Liu, Qi Pan, et al.
Communications Biology|April 1, 2024
UFObow: A single-wavelength excitable Brainbow for simultaneous multicolor ex-vivo and in-vivo imaging of mammalian cellsJiahong Hu, Fangfang Yang, Chong Liu, et al.
The Lancet. Gastroenterology & Hepatology|January 9, 2022
Camrelizumab plus apatinib as second-line treatment for advanced oesophageal squamous cell carcinoma (CAP 02): a single-arm, open-label, phase 2 trialXiangrui Meng, Tao Wu, Yonggui Hong, et al.
Pageof 5